FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000472017> ?p ?o ?g. }

• W3000472017 abstract "Abstract Background Early intervention in those patients not responding to a course of oral steroids following an Acute flare of their IBD is essential for improved outcomes. It enables re-assessment and escalation of treatment in those that are non-responders. We present our data on the effectiveness of an IBD nurse-led telephone follow-up appointment two weeks after commencing a course of oral steroids and its impact on outcomes. Methods Data collected prospectively on all patients treated with oral prednisolone between March and November 2019. Partial Mayo score for ulcerative colitis (UC) and clinical assessment of symptoms for Crohn’s disease (CD) patients were used to assess response to treatment at 2 weeks. Results 57 patients were treated with a Prednisolone reducing regime during the 8 months period. Patient demographics included 27 males and 30 females,19 CD and 38 UC patients with a median age of 48 (range 16–88). Following 2 weeks of treatment, 54% (31) of patients reported an improvement in symptoms-19 UC patients (Partial Mayo 0–4) and 12 CD patients. However, 45% (26) patients did not have a clinical improvement at week 2, 19 UC (Partial Mayo 2–9) and 7 CD were still symptomatic. In those patients who had not responded 3 were commenced on Azathioprine, 6 on Methotrexate and one patient had a slow response to steroids. Seven patients were escalated to receive biological therapy (3 vedolizumab, 2 infliximab, 1 ustekinumab and 1 adalimumab). Two other patients had their dose of vedolizumab increased, one patient was switched to another class of biologics. Three patients had a Flexible Sigmoidoscopy and following that 2 were admitted to receive IV steroids and escalated to biological therapy and Methotrexate. One patient was directly admitted for biological therapy, and 2 patients had an alternative diagnosis of Bile Salt Malabsorption which was treated. At the 3 months follow-up period all patients were well and had avoided further admissions or surgery, with only one patient electively opting for surgery. Conclusion Our data show that following a course of oral steroids for a flare of IBD, 45% are still symptomatic after 2 weeks. In this cohort, optimisation of treatment occurred in 23 patients (88%) with either the introduction of biological agents, or early introduction of immunomodulatory therapy. We believe that These data supports the implementation of an early review with appropriate intervention, demonstrating improved patient outcomes." @default.
• W3000472017 created "2020-01-23" @default.
• W3000472017 creator A5017431432 @default.
• W3000472017 creator A5023383121 @default.
• W3000472017 creator A5056545432 @default.
• W3000472017 creator A5060587289 @default.
• W3000472017 creator A5075426406 @default.
• W3000472017 date "2020-01-01" @default.
• W3000472017 modified "2023-09-26" @default.
• W3000472017 title "P660 Evaluating the effectiveness of disease assessment at 2 weeks following a course of oral steroids: Does early intervention affect outcomes?" @default.
• W3000472017 doi "https://doi.org/10.1093/ecco-jcc/jjz203.788" @default.
• W3000472017 hasPublicationYear "2020" @default.
• W3000472017 type Work @default.
• W3000472017 sameAs 3000472017 @default.
• W3000472017 citedByCount "0" @default.
• W3000472017 crossrefType "journal-article" @default.
• W3000472017 hasAuthorship W3000472017A5017431432 @default.
• W3000472017 hasAuthorship W3000472017A5023383121 @default.
• W3000472017 hasAuthorship W3000472017A5056545432 @default.
• W3000472017 hasAuthorship W3000472017A5060587289 @default.
• W3000472017 hasAuthorship W3000472017A5075426406 @default.
• W3000472017 hasBestOaLocation W30004720171 @default.
• W3000472017 hasConcept C126322002 @default.
• W3000472017 hasConcept C141071460 @default.
• W3000472017 hasConcept C197934379 @default.
• W3000472017 hasConcept C2776207728 @default.
• W3000472017 hasConcept C2776715498 @default.
• W3000472017 hasConcept C2776760755 @default.
• W3000472017 hasConcept C2777138892 @default.
• W3000472017 hasConcept C2778260677 @default.
• W3000472017 hasConcept C2779134260 @default.
• W3000472017 hasConcept C2779280984 @default.
• W3000472017 hasConcept C2780132546 @default.
• W3000472017 hasConcept C2780479503 @default.
• W3000472017 hasConcept C71924100 @default.
• W3000472017 hasConceptScore W3000472017C126322002 @default.
• W3000472017 hasConceptScore W3000472017C141071460 @default.
• W3000472017 hasConceptScore W3000472017C197934379 @default.
• W3000472017 hasConceptScore W3000472017C2776207728 @default.
• W3000472017 hasConceptScore W3000472017C2776715498 @default.
• W3000472017 hasConceptScore W3000472017C2776760755 @default.
• W3000472017 hasConceptScore W3000472017C2777138892 @default.
• W3000472017 hasConceptScore W3000472017C2778260677 @default.
• W3000472017 hasConceptScore W3000472017C2779134260 @default.
• W3000472017 hasConceptScore W3000472017C2779280984 @default.
• W3000472017 hasConceptScore W3000472017C2780132546 @default.
• W3000472017 hasConceptScore W3000472017C2780479503 @default.
• W3000472017 hasConceptScore W3000472017C71924100 @default.
• W3000472017 hasLocation W30004720171 @default.
• W3000472017 hasOpenAccess W3000472017 @default.
• W3000472017 hasPrimaryLocation W30004720171 @default.
• W3000472017 hasRelatedWork W1018394 @default.
• W3000472017 hasRelatedWork W12352589 @default.
• W3000472017 hasRelatedWork W13209649 @default.
• W3000472017 hasRelatedWork W1966515 @default.
• W3000472017 hasRelatedWork W422488 @default.
• W3000472017 hasRelatedWork W5273617 @default.
• W3000472017 hasRelatedWork W5861673 @default.
• W3000472017 hasRelatedWork W6763045 @default.
• W3000472017 hasRelatedWork W754091 @default.
• W3000472017 hasRelatedWork W9287141 @default.
• W3000472017 isParatext "false" @default.
• W3000472017 isRetracted "false" @default.
• W3000472017 magId "3000472017" @default.
• W3000472017 workType "article" @default.